Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
In the latest session, Xylem Inc (NYSE: XYL) closed at $121.31 up 0.32% from its previous closing price of $120.92. In other words, the price has increased by $0.32 from its previous closing price. On the day, 1.65 million shares were traded. XYL stock price reached its highest trading level at $122.1889 during the session, while it also had its lowest trading level at $120.33.
Ratios:
For a deeper understanding of Xylem Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 26.30 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 31.30. For the most recent quarter (mrq), Quick Ratio is recorded 1.33 and its Current Ratio is at 1.75. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.21.
On December 09, 2024, Citigroup Upgraded its rating to Buy which previously was Neutral and also upped its target price recommendation from $135 to $148.
TD Cowen Downgraded its Buy to Hold on September 03, 2024, while the target price for the stock was maintained at $138.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 07 ’25 when GERI-MICHELLE MCSHANE bought 4,119 shares for $128.18 per share.
McShane Geri-Michelle sold 4,119 shares of XYL for $527,978 on Mar 07 ’25. The VP, Controller & CAO now owns 3,950 shares after completing the transaction at $128.18 per share. On Mar 04 ’25, another insider, Capers Dorothy Trefon, who serves as the SVP & General Counsel of the company, sold 12,026 shares for $127.26 each. As a result, the insider received 1,530,391 and left with 8,015 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, XYL now has a Market Capitalization of 29483909120 and an Enterprise Value of 31045937152. As of this moment, Xylem’s Price-to-Earnings (P/E) ratio for their current fiscal year is 33.20, and their Forward P/E ratio for the next fiscal year is 23.17. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.91. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.44 while its Price-to-Book (P/B) ratio in mrq is 2.77. Its current Enterprise Value per Revenue stands at 3.626 whereas that against EBITDA is 18.447.
Stock Price History:
The Beta on a monthly basis for XYL is 1.07, which has changed by -0.06677437 over the last 52 weeks, in comparison to a change of 0.08275449 over the same period for the S&P500. Over the past 52 weeks, XYL has reached a high of $146.08, while it has fallen to a 52-week low of $113.26. The 50-Day Moving Average of the stock is -2.74%, while the 200-Day Moving Average is calculated to be -6.30%.
Shares Statistics:
For the past three months, XYL has traded an average of 1.38M shares per day and 1502990 over the past ten days. A total of 242.99M shares are outstanding, with a floating share count of 241.50M. Insiders hold about 0.64% of the company’s shares, while institutions hold 94.47% stake in the company. Shares short for XYL as of 1740700800 were 3408497 with a Short Ratio of 2.48, compared to 1738281600 on 3083764. Therefore, it implies a Short% of Shares Outstanding of 3408497 and a Short% of Float of 1.79.
Dividends & Splits
According to the company, the forward annual dividend rate for XYL is 1.48, from 1.44 in the trailing year. Against a Trailing Annual Dividend Yield of 0.011908701The stock’s 5-year Average Dividend Yield is 1.15.
